Compare Stocks

Compare up to 5 stocks side by side with metrics, growth rates, and performance charts

Select Stocks
CI
GSK

Add up to 3 more stocks

Open the full CI vs GSK breakdown — total return with dividends reinvested, side-by-side tables, and evidence links
Metric
ValuationTTM multiples, at last close
P/E Ratio11.5216.49
Forward P/E9.1414.58
P/B Ratio1.724.56
P/S Ratio0.262.39
P/FCF Ratio8.0611.36
EV/EBITDA8.038.46
Profitabilitytrailing twelve months
Gross Margin11.7%72.7%
Operating Margin3.5%20.7%
Net Margin2.3%14.5%
ROE15.1%27.7%
ROA4.1%7.9%
ROIC7.3%16.6%
Financial Healthlatest reported quarter
Current Ratio0.850.82
Quick Ratio0.740.52
Debt/Equity0.751.03
Interest Coverage6.6112.14
Dividendstrailing dividends vs latest price
Dividend Yield2.2%3.4%
Payout Ratio27.5%47.3%
Yrs of Dividend Growth52

N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.